Literature DB >> 30027669

Clinical and genetic ancestry profile of a large multi-centre sickle cell disease cohort in Brazil.

Anna B F Carneiro-Proietti1, Shannon Kelly2,3, Carolina Miranda Teixeira1, Ester C Sabino4, Cecilia S Alencar4, Ligia Capuani5, Tassila P Salomon Silva1, Aderson Araujo6, Paula Loureiro6, Cláudia Máximo7, Clarisse Lobo7, Miriam V Flor-Park8, Daniela O W Rodrigues1, Rosimere A Mota1, Thelma T Gonçalez2, Carolyn Hoppe3, João E Ferreira4, Mina Ozahata4, Grier P Page9, Yuelong Guo9, Liliana R Preiss9, Donald Brambilla9, Michael P Busch2, Brian Custer2.   

Abstract

Approximately 3500 children with sickle cell disease (SCD) are born in Brazil each year, but the burden of SCD morbidity is not fully characterised. A large, multi-centre cohort was established to characterise clinical outcomes in the Brazilian SCD population and create the infrastructure to perform genotype-phenotype association studies. Eligible patients were randomly selected from participating sites and recruited at routine visits. A biorepository of blood samples was created and comprehensive demographic and clinical outcome data were entered in a centralized electronic database. Peripheral blood genome-wide single nucleotide polymorphism (SNP) genotyping was performed using a customized Transfusion Medicine (TM) Array. A total of 2795 participants at six Brazilian sites were enrolled between 2013 and 2015. The cohort included slight predominance of children <18 years (55·9%) and females (53·0%). Haemoglobin (Hb) SS was the most common SCD genotype (70·7%), followed by HbSC (23%), Sβ0 (3·0%) and Sβ+ (2·9%). SNP data from the TM Array were analysed to evaluate the genetic ancestry of the cohort and revealed significant admixture among the population. Demographics and clinical complications, stratified by age and SCD genotype, are summarized and future studies in this cohort are discussed.
© 2018 British Society for Haematology and John Wiley & Sons Ltd.

Entities:  

Keywords:  clinical aspects; sickle cell disease; single nucleotide polymorphisms

Mesh:

Substances:

Year:  2018        PMID: 30027669      PMCID: PMC8019534          DOI: 10.1111/bjh.15462

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  22 in total

1.  Cognitive deficits are associated with unemployment in adults with sickle cell anemia.

Authors:  Maureen Sanger; Lori Jordan; Sumit Pruthi; Matthew Day; Brittany Covert; Brenda Merriweather; Mark Rodeghier; Michael DeBaun; Adetola Kassim
Journal:  J Clin Exp Neuropsychol       Date:  2016-08       Impact factor: 2.475

Review 2.  Sickle Cell Disease.

Authors:  Frédéric B Piel; Martin H Steinberg; David C Rees
Journal:  N Engl J Med       Date:  2017-04-20       Impact factor: 91.245

Review 3.  Intravascular hemolysis and the pathophysiology of sickle cell disease.

Authors:  Gregory J Kato; Martin H Steinberg; Mark T Gladwin
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

Review 4.  The inherited diseases of hemoglobin are an emerging global health burden.

Authors:  David J Weatherall
Journal:  Blood       Date:  2010-03-16       Impact factor: 22.113

5.  Cerebrovascular accidents in sickle cell disease: rates and risk factors.

Authors:  K Ohene-Frempong; S J Weiner; L A Sleeper; S T Miller; S Embury; J W Moohr; D L Wethers; C H Pegelow; F M Gill
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

6.  Ancestry of African Americans with sickle cell disease.

Authors:  Nadia Solovieff; Stephen W Hartley; Clinton T Baldwin; Elizabeth S Klings; Mark T Gladwin; James G Taylor; Gregory J Kato; Lindsay A Farrer; Martin H Steinberg; Paola Sebastiani
Journal:  Blood Cells Mol Dis       Date:  2011-05-04       Impact factor: 3.039

Review 7.  Differences in the clinical and genotypic presentation of sickle cell disease around the world.

Authors:  Santosh L Saraf; Robert E Molokie; Mehdi Nouraie; Craig A Sable; Lori Luchtman-Jones; Gregory J Ensing; Andrew D Campbell; Sohail R Rana; Xiao M Niu; Roberto F Machado; Mark T Gladwin; Victor R Gordeuk
Journal:  Paediatr Respir Rev       Date:  2013-11-15       Impact factor: 2.726

8.  Demographic and epidemiologic characterization of transfusion recipients from four US regions: evidence from the REDS-III recipient database.

Authors:  Matthew S Karafin; Roberta Bruhn; Matt Westlake; Marian T Sullivan; Walter Bialkowski; Gustaf Edgren; Nareg H Roubinian; Ronald G Hauser; Daryl J Kor; Debra Fleischmann; Jerome L Gottschall; Edward L Murphy; Darrell J Triulzi
Journal:  Transfusion       Date:  2017-10-24       Impact factor: 3.157

9.  The National Heart, Lung, and Blood Institute Recipient Epidemiology and Donor Evaluation Study (REDS-III): a research program striving to improve blood donor and transfusion recipient outcomes.

Authors:  Steven Kleinman; Michael P Busch; Edward L Murphy; Hua Shan; Paul Ness; Simone A Glynn
Journal:  Transfusion       Date:  2013-11-04       Impact factor: 3.157

10.  Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania.

Authors:  Julie Makani; Sharon E Cox; Deogratius Soka; Albert N Komba; Julie Oruo; Hadija Mwamtemi; Pius Magesa; Stella Rwezaula; Elineema Meda; Josephine Mgaya; Brett Lowe; David Muturi; David J Roberts; Thomas N Williams; Kisali Pallangyo; Jesse Kitundu; Gregory Fegan; Fenella J Kirkham; Kevin Marsh; Charles R Newton
Journal:  PLoS One       Date:  2011-02-16       Impact factor: 3.240

View more
  15 in total

1.  Diversity of RH and transfusion support in Brazilian sickle cell disease patients with unexplained Rh antibodies.

Authors:  Carla L Dinardo; Shannon Kelly; Marcia R Dezan; Ingrid H Ribeiro; Shirley L Castilho; Luciana C Schimidt; Maria do C Valgueiro; Liliana R Preiss; Brian Custer; Ester C Sabino; Connie M Westhoff
Journal:  Transfusion       Date:  2019-08-13       Impact factor: 3.157

2.  Prevalence of serologic markers of transfusion and sexually transmitted infections and their correlation with clinical features in a large cohort of Brazilian patients with sickle cell disease.

Authors:  Paula F Blatyta; Shannon Kelly; Ester Sabino; Liliana Preiss; Franciane Mendes; Anna B Carneiro-Proietti; Daniela de Oliveira Werneck Rodrigues; Rosimere Mota; Paula Loureiro; Claudia Maximo; Miriam Park; Alfredo Mendrone-Jr; Thelma T Gonçalez; Cesar de Almeida Neto; Brian Custer
Journal:  Transfusion       Date:  2019-12-05       Impact factor: 3.157

3.  Influence of UGT1A1 promoter polymorphism, α-thalassemia and βs haplotype in bilirubin levels and cholelithiasis in a large sickle cell anemia cohort.

Authors:  Jéssica V G F Batista; Gabriela S Arcanjo; Thais H C Batista; Marcondes J Sobreira; Rodrigo M Santana; Igor F Domingos; Betânia L Hatzlhofer; Diego A Falcão; Diego A Pereira-Martins; Jéssica M Oliveira; Amanda S Araujo; Luana P M Laranjeira; Fernanda S Medeiros; Flávia P Albuquerque; Dulcinéia M Albuquerque; Magnun N Santos; Manuela F Hazin; Ana C Dos Anjos; Fernando F Costa; Aderson S Araujo; Antonio R Lucena-Araujo; Marcos A Bezerra
Journal:  Ann Hematol       Date:  2021-02-01       Impact factor: 3.673

4.  Phenotypes of sickle cell intensive care admissions: an unsupervised machine learning approach in a single-center retrospective cohort.

Authors:  Eduardo Messias Hirano Padrão; Brian Bustos; Ashwin Mahesh; Guilherme Henrique Hencklain Fonseca; Leandro Utino Taniguchi
Journal:  Ann Hematol       Date:  2022-07-15       Impact factor: 4.030

5.  Economic burden of sickle cell disease in Brazil.

Authors:  Ana Cristina Silva-Pinto; Fernando F Costa; Sandra Fatima Menosi Gualandro; Patricia Belintani Blum Fonseca; Carmela Maggiuzzu Grindler; Homero C R Souza Filho; Carolina Tosin Bueno; Rodolfo D Cançado
Journal:  PLoS One       Date:  2022-06-16       Impact factor: 3.752

6.  The Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P): A research program striving to improve blood donor safety and optimize transfusion outcomes across the lifespan.

Authors:  Cassandra D Josephson; Simone Glynn; Sunitha Mathew; Rebecca Birch; Sonia Bakkour; Lisa Baumann Kreuziger; Michael P Busch; Kathleen Chapman; Carla Dinardo; Jeanne Hendrickson; Eldad A Hod; Shannon Kelly; Naomi Luban; Alan Mast; Philip Norris; Brian Custer; Ester Sabino; Bruce Sachais; Bryan R Spencer; Mars Stone; Steve Kleinman
Journal:  Transfusion       Date:  2022-04-19       Impact factor: 3.337

7.  Development and evaluation of a transfusion medicine genome wide genotyping array.

Authors:  Yuelong Guo; Michael P Busch; Mark Seielstad; Stacy Endres-Dighe; Connie M Westhoff; Brendan Keating; Carolyn Hoppe; Aarash Bordbar; Brian Custer; Adam S Butterworth; Tamir Kanias; Alan E Mast; Steve Kleinman; Yontao Lu; Grier P Page
Journal:  Transfusion       Date:  2018-11-20       Impact factor: 3.157

8.  Hb S/β-Thalassemia in the REDS-III Brazil Sickle Cell Disease Cohort: Clinical, Laboratory and Molecular Characteristics.

Authors:  André R Belisário; Anna B Carneiro-Proietti; Ester Cerdeira Sabino; Aderson Araújo; Paula Loureiro; Cláudia Máximo; Miriam V Flor-Park; Daniela D O W Rodrigues; Mina Cintho Ozahata; Christopher McClure; Rosimere Afonso Mota; Isabel C Gomes Moura; Brian Custer; Shannon Kelly
Journal:  Hemoglobin       Date:  2020-03-16       Impact factor: 0.849

9.  Quality of life in pre-adolescent children with sickle cell disease in Brazil.

Authors:  Claudia Di Lorenzo Oliveira; Shannon Kelly; Cesar de Almeida-Neto; Anna Barbara Carneiro-Proietti; Fabiana Chagas Camargos Piassi; Tassila Salomon; Miriam V Flor-Park; Claudia Maximo; Daniela Werneck Rodrigues; Rosimere Afonso Mota; Carolina Miranda Teixeira; Paula Loureiro; Ester Cerdeira Sabino; Brian Custer
Journal:  Pediatr Hematol Oncol       Date:  2019-09-06       Impact factor: 1.969

10.  Clinical and Genetic Predictors of Priapism in Sickle Cell Disease: Results from the Recipient Epidemiology and Donor Evaluation Study III Brazil Cohort Study.

Authors:  Mina Cintho Ozahata; Grier P Page; Yuelong Guo; João Eduardo Ferreira; Carla Luana Dinardo; Anna Bárbara F Carneiro-Proietti; Paula Loureiro; Rosimere Afonso Mota; Daniela O W Rodrigues; André Rolim Belisario; Claudia Maximo; Miriam V Flor-Park; Brian Custer; Shannon Kelly; Ester Cerdeira Sabino
Journal:  J Sex Med       Date:  2019-10-24       Impact factor: 3.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.